🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Apotex Health Corp. (TSX:APTX)
Canada flag Canada · Delayed Price · Currency is CAD
41.70
+0.53 (1.29%)
Nov 19, 2026, 4:00 PM EST

Apotex Health Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Apotex Health stock has a consensus rating of "Buy" and an average price target of $44.13. The average 1-year stock price forecast is 5.83% higher than the current stock price, while the lowest is $40.00 (-4.08%) and the highest is $48.00 (+15.11%).

Price Target: $44.13 (+5.83%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$40.00$44.13$44.65$48.00
Change-4.08%+5.83%+7.07%+15.11%

Analyst Ratings

The average analyst rating for Apotex Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy67776
Buy77668
Hold00000
Sell00000
Strong Sell00000
Total1314131314

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$42.00 → $43.00
BuyMaintains$42.00 → $43.00+3.12%Nov 18, 2026
CIBC
CIBC
Buy
Reiterates
$40.00 → $45.00
BuyReiterates$40.00 → $45.00+7.91%Nov 13, 2026
RBC Capital
RBC Capital
Buy
Maintains
$43.00 → $46.00
BuyMaintains$43.00 → $46.00+10.31%Nov 13, 2026
Bloom Burton
Bloom Burton
Buy
Maintains
$40.00
BuyMaintains$40.00-4.08%Aug 13, 2026
BMO Capital
BMO Capital
Buy
Reiterates
$39.00 → $43.00
BuyReiterates$39.00 → $43.00+3.12%Aug 13, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.44B
from 3.49B
Decreased by -1.59%
Revenue Next Year
3.71B
from 3.44B
Increased by 8.09%
EPS This Year
2.23
EPS Next Year
2.36
from 2.23
Increased by 5.75%
Fiscal YearFY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
2.94B3.35B3.49B3.44B
Revenue Growth
-13.92%4.22%-1.59%
Gross Profit
1.32B1.82B1.94B1.73B
Gross Margin
44.97%54.34%55.65%50.43%
Operating Income
628.71M997.98M1.07B622.06M
Net Income
-146.92M151.70M373.78M224.01M
EPS
---2.23
Forward PE
---18.69
Dividend / Share
5.066.48-0.16
Free Cash Flow
---315.34M
No. Analysts
---14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue202720282029
High3.5B
Avg3.4B
Low3.4B

Revenue Growth

Revenue Growth202720282029
High
-1.1%
Avg
-1.6%
Low
-2.9%

EPS Forecast

EPS202720282029
High2.38
Avg2.23
Low2.14

EPS Growth

EPS Growth20282029
High
17.4%
Avg
5.7%
Low
-1.8%